DIRS.INFO The most relevant business & tech news

☆ Jefferies upgrades Eli Lilly as enthusiasm around weight-loss drugs grows following Wegovy study
▼ + stars: | 2023-08-09 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Jefferies is encouraged by recent results from a weight-loss drug study that could help lift Eli Lilly . Analyst Akash Tewari lauded the strong results from a recent trial study surrounding Novo Nordisk's weight loss drug Wegovy . Eli Lilly also raised its full-year guidance on Tuesday. Eli Lilly as added more than 42% upside from the start of the year. LLY YTD mountain Eli Lilly year to date — CNBC's Michael Bloom contributed to this report.

Persons: Jefferies, Eli Lilly, Akash Tewari, Wegovy, Tewari, Eli Lilly's, NVO, Michael Bloom

☆ Goldman Sachs names ‘directors’ cut’ conviction list stocks — and adds 2 names
▼ + stars: | 2023-08-02 | by ( Lucy Handley | ) www.cnbc.com time to read: +2 min

Goldman Sachs highlighted a slew of stocks on its U.S. "conviction list — director's cut" selection, naming several "most differentiated buy recommendations," in an August 1 research note. Goldman's "directors' cut" is a list of stocks chosen by its U.S. research analysts and managers. The bank collated a list of "top ideas that offer a combination of conviction, a differentiated view and high risk-adjusted returns," before shortlisting 20 to 25 names. Industrial names on the bank's "directors' cut" list included several that Goldman said are benefiting from post-pandemic demand, such as building services firm Johnson Controls and waste disposal company Republic Services . Goldman's note also included a "What has worked" heading, under which its analysts named three stocks.

Persons: Goldman Sachs, Goldman's, Goldman, Johnson, Baker Hughes, – EBITDA, JB Hunt, Jordan Alliger, Michael Bloom Organizations: Apple, Healthcare, Merck, Services, Consumer, Body, International, Chevron, JPMorgan

☆ Amazon CEO Andy Jassy now has 16 direct reports. See the growing and evolving list here, including a newly promoted executive from Alexa.
▼ + stars: | 2023-07-31 | by ( Eugene Kim | ) www.businessinsider.com time to read: +3 min

Amazon CEO Andy Jassy recently expanded his group of direct reports. Jassy has added at least 8 new executives to his direct reports since becoming CEO in 2021. Amazon recently created a new AI group that reports to CEO Andy Jassy. In his 2 years since becoming CEO, Jassy has added or replaced at least 8 executives in his top leadership team. (Jassy's direct reports are different from the S-team, a group of more than two dozen most senior decision-makers at Amazon).

Persons: Andy Jassy, Rohit Prasad, Prasad, Doug Herrington, Adam Selipsky, Brian Olsavsky, Jassy, There's, Dave Clark, Jay Carney, Jeff Blackburn, James Hamilton, Mike Hopkins, Eric Remling, Beth, Dave Limp, David Zapolsky, Drew Herdener, WW Communications Eric Rimling, Paul Kotas, Peter Krawiec, Alexa Stacey Pistole, Steve Boom, Steve Schmidt, Eugene Kim Organizations: Amazon, Alexa, Business, Amazon Studios, Amazon Devices, WW Amazon, WW Communications, Amazon Video, Corporate Locations: It's

☆ On tap this week: Jobs report plus 10 key earnings. Here's what we want to see
▼ + stars: | 2023-07-29 | by ( Zev Fima | ) www.cnbc.com time to read: +18 min

All three major averages advanced for the week, powered by strong mega-cap earnings and favorable inflation data. Looking to next week, earnings season enters its second half with the last of our mega-caps — Apple (AAPL) and Amazon (AMZN) — set to report on Thursday. We'll get a better read on the employment picture on Wednesday with the ADP report and then, more importantly, on Friday's nonfarm payrolls report for July. Thursday after the close brings us to the main events of the week: Earnings from Apple and Amazon. For those looking to review first quarter performance ahead of these releases, be sure to keep our first-quarter earnings report card handy.

Persons: We'll, that's, Stanley Black, Decker, Emerson, Bausch, Leggett, Platt, SIRI, Ares, COLM, PERI, Kraft Heinz, Phillips, Ferrari N.V, Johnson, Robinson, COOK, BUD, Kellogg, Papa, Pitney Bowes, Parker, Trimble, Ziff Davis, Nonfarm, Jim Cramer's, Jim Cramer, Jim, Apple Tim Cook, Kevin Dietsch Organizations: Nasdaq, Dow, Federal Reserve, Federal, ISM Manufacturing, Services PMI, Investors, Caterpillar, Devices, Starbucks, Natural Resources, AMD, Management, Emerson Electric and, Humana, Bausch Health, Apple, Microsoft, Resource Partners, AerCap Holdings, CNA Financial Corp, CNA, Apellis Pharmaceuticals, Bank, SJW, Hutchison China MediTech, Camtek Ltd, Silvercrest Asset Management, Loews Corp, Oxford Lane Capital Corp, Banco Santander, Silicom Ltd, SuperCom Ltd, Arista Networks, Avis Budget Group, Diamondback Energy, Lattice Semiconductor Corp, Republic Services, Yum China Holdings, Western Digital Corp, Power Systems, Tenet Healthcare Corp, Vornado Realty, BioMarin Pharmaceutical, PetMed, SBA Communications Corporation, Brixmor, Snack Foods Corp, Cushman & Wakefield, Sanmina Corporation, TFI, PMI, Cruise Line Holdings Ltd, Uber Technologies, Pfizer, Enterprise Products Partners, Merck, JetBlue Airways Corporation, Allegro MicroSystems, Altria, SunPower Corp, SiriusXM Holdings, Molson Coors Beverage, Marriott International, Toyota Motor Corp, BP, SYSCO Corp, Marathon Petroleum Corp, Ares Management, Equitrans Midstream Corporation, Game Technology, Illinois Tool, IDEXX Laboratories, Rockwell Automation, Packaging International Corp, Gartner, Zebra Technologies Corp, IQVIA Holdings, Oshkosh Corporation, Leidos Holdings, Eaton Corp, yte Corp, Lear Corp, Starbucks Corp, Devon Energy Corp, SolarEdge Technologies, Lumen Technologies, Virgin Galactic Holdings, Caesars Entertainment, VF Corp, Sciences Corp, Paycom, Vertex Pharmaceuticals, Suncor Energy, Holdings, Chesapeake Energy Corp, Boston Properties, American International Group, AIG, Allstate Corp, Aspen Technology, Electronic Arts, EA, Flowserve Corporation, Denny's, Corp, Prudential Financial, Store, Ternium S.A, Vimeo, Emerson, Lomb, CVS Health, Generac Holdings, Cameco Corp, Perion Network Ltd, Builders, Carlyle Group, Scorpio, Teva Pharmaceutical Industries, Ltd, Rithm Capital Corp, AeroSystems Holdings, Vertiv Holdings Co, Johnson Controls, CDW Corp, DuPont, Brands Holdings, Scotts Miracle, Gro, SMG, Brands, Allegheny Technologies, AmerisourceBergen Corporation, ABC, Real Estate Corporation, Adient plc, Editas, Garmin Ltd, WWE, Bunge Ltd, Criteo S.A, PayPal, QUALCOMM, Occidental Petroleum Corp, Apache Corp, Albemarle Corp, MGM Resorts International, MGM, Marathon Oil Corp, Joby Aviation, Industrial, CF Industries Holdings, Goodyear Tire &, Realty ome Corp, Metlife, Pacific Biosciences of, Rush Street Interactive, Zillow, JFrog Ltd, Herbalife Nutrition Ltd, Simon Property Group, McKesson Corp, Storage, Cerus Corporation, GXO Logistics, MAX Holdings, Health, Anheuser, Busch InBev, Warner Bros ., Cheniere Energy, ConocoPhillips, Hasbro, CIGNA Corp, Lantheus Holdings, Regeneron Pharmaceuticals, Fiverr International, Air Products & Chemicals, TopBuild Corp, EPAM Systems, Lightspeed Commerce, Aurinia Pharmaceuticals, Cummins, CMI, Slair Corporation, Starwood Property Trust, Vulcan, Alnylam Pharmaceuticals, New Energy Corp, Cedar Fair Entertainment, Intellia Therapeutics, Lending, Privia Health, Dickinson, Chimera Investment, CIM, Hyatt Hotels Corp, Lion Electric, LEV, Deluxe Corp, Murphy Oil Corp, PBF Energy, Papa John's, Targa Resources Corp, Wix.com Ltd, Apollo Global Management, LLC, Butterfly, Sempra Energy, Aptiv PLC, Brookfield Infrastructure Partners, Canada Goose Holdings, Hannifin Corporation, WESCO International, WCC, Arrow Electronics, Constellation Energy Group, Midstream Partners, Coinbase, Petroleo Brasileiro SA Petrobras, Gilead Sciences, Opendoor Technologies, Booking Holdings, Atlassian Corporation, International, Redfin Corporation, Motorola Solutions, Monster Beverage Corporation, Consolidated Edison, Rocket Companies, Apple Hospitality, Cirrus, Resources, Universal Display Corporation, Chesapeake Utilities Corp, Social, Defense, Security Solutions, Post Holdings, Tandem Diabetes Care, Nikola Corporation, Magna International, Dominion Energy, ACM Research, Frontier Communications, Brookfield Renewable Partners, inTEST Corporation, American Pipeline, TELUS International, XPO Logistics, Fluor Corp, Gray Television, Cboe, LyondellBasell Industries, Twist Bioscience, Global, Jim Cramer's Charitable, CNBC, Allen & Company Sun Valley, Getty Locations: U.S, China, India, Oxford, Chile, Illinois, Columbia, Pacific, Pacific Biosciences of California, Southern, PBI, Gilead, Sun Valley , Idaho

☆ Buy stocks like Amazon, which are undervalued and underappreciated ahead of earnings, analysts say
▼ + stars: | 2023-07-29 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Investors combing for value ahead of another big week of earnings should look no further, according to analysts. CNBC Pro looked through top Wall Street research to find stocks that are underappreciated as earnings season continues. Meanwhile chatter around the stock remains mostly balanced and positive, according to UBS. "We model an ~8% 5-yr. EPS CAGR and rate the stock buy as we believe this growth potential remains underappreciated," Serna said. ... We model an ~8% 5-yr. EPS CAGR and rate the stock buy as we believe this growth potential remains underappreciated."

Persons: Mauricio Serna, Lee, Wrangler, Serna, Jason Kupferberg, it's, Kupferberg, Matt Niknam, DigitalBridge, Niknam, Baird, Jassy, DBRG, Morgan Stanley Organizations: CNBC Pro, Kontoor Brands, International, Kontoor Brands UBS, UBS, Bank of America, Deutsche Bank, TAM

☆ Here are Wednesday's biggest analyst calls: Microsoft, Amazon, Apple, Netflix, Spotify, Meta & more
▼ + stars: | 2023-07-26 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are the biggest calls on Wall Street on Wednesday: Morgan Stanley reiterates Amazon as overweight Morgan Stanley said it's bullish on the e-commerce giant's earnings next week. Morgan Stanley downgrades RTX to equal weight from overweight Morgan Stanley said in its downgrade of the stock that risk/reward seems "balanced" right now. Morgan Stanley upgrades WW International to overweight from equal weight Morgan Stanley said shares of the company formerly known as Weight Watchers are underappreciated. Citi reiterates Meta as a top pick Citi said Meta is a top pick heading into earnings on Wednesday afternoon. Morgan Stanley reiterates General Motors as overweight Morgan Stanley said the stock's weak reaction to Tuesday's GM earnings report is a "headscratcher."

Persons: Morgan Stanley, it's bullish, it's, Raymond James downgrades, Raymond James, Morgan Stanley downgrades RTX, Needham, NFLX, Citi, Eli Lilly, Elliot, Burger, Disney, TD Cowen, bitcoin, GOOGL Organizations: Deutsche Bank, Spotify, Deutsche, Barclays, Apple, Target, Bank of America, NXP Semiconductors, International, Netflix, Citi, Goodyear Tire Deutsche, Elliot Management, Goodyear, Elliott Management, Operational, Restaurant Brands Citi, Microsoft, Hollywood, Meta, JPMorgan, United Airline, AFL, DAL, Motors, UAW Locations: 1Q23

☆ Buy this weight loss stock that can rally 30%, Morgan Stanley says
▼ + stars: | 2023-07-26 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

WW International could be in for big gains ahead, according to Morgan Stanley. The bank upgraded the company formerly known as Weight Watchers to overweight from equal weight. Shares of WW International popped more than 7% in the premarket. WW YTD mountain WW in 2023 Analyst Lauren Schenk said the company will benefit from its acquisition of Sequence, which gives WW International exposure to weight loss drugs. WW International announced in March its Sequence acquisition for $106 million.

Persons: Morgan Stanley, Lauren Schenk, Schenk, — CNBC's Michael Bloom Organizations: International, WW International

☆ Stocks making the biggest midday moves: Microsoft, Alphabet, Boeing and more
▼ + stars: | 2023-07-26 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +3 min

Microsoft — The Xbox owner saw its shares slide 3.7% after issuing quarterly revenue guidance that fell short of analysts' expectations. Microsoft did report earnings and revenue that beat Street estimates for the calendar second quarter, however. Alphabet — Shares of the Google parent rose 5.8% after Alphabet beat analysts' revenue and profit in the second quarter. Boeing's revenue of $19.75 billion topped analysts' estimates of $18.45 billion, according to Refinitiv. The company also reported an 82-cent-loss per share, while Refinitiv analysts had estimated a loss of 88 cents per share.

Persons: Refinitiv, Morgan Stanley, Lauren Schenk, Chubb, Spotify's, selloff, PacWest, Warburg Pincus Organizations: Microsoft, YouTube, Boeing, Texas, Texas Instruments, FactSet, Visa, Spotify, Deutsche Bank, Warburg, Centerbridge Locations: Banc, California

☆ WeightWatchers could either win big or lose faithful customers, or both, in its pivot to Ozempic trend
▼ + stars: | 2023-07-22 | by ( Jordan Hart | ) www.businessinsider.com time to read: +3 min

Sequence offers access to weight-loss drugs like Ozempic and Wegovy. Analysts say the move could save the company, but some WeightWatchers members aren't happy. Although the medication has gained popularity online and among celebrities, veteran WeightWatchers members aren't all happy with the company's pivot. Some WeightWatchers members expressed concern that the company was abandoning its message of self-restraint for the easy solution of weight-loss medication. Sequence, meanwhile, prescribes weight-loss medications like Ozempic and Wegovy and helps patients afford the drugs through insurance and reimbursements.

Persons: WeightWatchers, aren't, They're, Goldman Sachs, Sima Sistani, Jenny Craig Organizations: WW, Inc, Bloomberg, Employers

☆ Goldman adds a utility stock to its list of elite picks for clients
▼ + stars: | 2023-07-03 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

As the third quarter and second half open, Goldman Sachs is adding a key utility stock to its high-conviction stock list. These are some of the other names that made the cut: Goldman views the potential launch of an iPhone 15 come September as a big potential catalyst for shares of Apple. Like its peers, Apple shares have been on a tear in 2023, surging roughly 49% in the first half as Wall Street bet on artificial intelligence and returned to tech after a terrible 2022. WW International is positioned for the most upside potential among all the stocks on Goldman's list, with a $13 price target implying that shares can nearly double. Other key names highlighted in the list include Amazon , Warner Bros Discovery , Merck and JPMorgan Chase .

Persons: Goldman Sachs, Goldman, Steven Kron, — CNBC's Michael Bloom Organizations: Southern Company, Atlanta, Apple, Warner Bros Discovery, Merck, JPMorgan Chase

☆ Meta vs. TikTok: How they're each using AI to attract advertisers and which one is winning
▼ + stars: | 2023-06-07 | by ( Paulina Likos | ) www.cnbc.com time to read: +14 min

The aim was a similar short-form video service to become more competitive in the space and slow down ad share losses. "This is a key leading indicator for monetization, and any incremental results from AI-driven targeting and measurement would accelerate the market share shift." In a digital advertising market where growth is limited, the battle for market share gains is critical. TikTok's AI strategy TikTok has seen a quick rise in viewership by virtue of predictive AI for content recommendation. TikTok advertisers can place ads through the platform's TikTok Ads Manager , offering automatic audience targeting and measurement tools.

Persons: TikTok, Debra Aho Williamson, Instagram, Aho Williamson, Rohit Kulkarni, Roth MKM, Kulkarni, Roth MKM Kulkarni, Oppenheimer, That's, Brad Erickson, Meta, Erickson, Meta's, Mark Zuckerberg's, Roth, Joe Biden, it's, we're, Jim Cramer's, Jim Cramer, Jim, Rafael Henrique, Lightrocket Organizations: Facebook, TikTok, Meta, Insider Intelligence, Apple, CNBC, JMP Securities, RBC Capital, Citi, —, Oracle, Getty Locations: Beijing, Instagram, U.S, Montana

☆ Jenny Craig is going out of business
▼ + stars: | 2023-05-05 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +3 min

New York CNN —Jenny Craig, the weight-loss chain, has confirmed that it’s shutting down for good. Named after its founder, the Jenny Craig business started when she couldn’t lose weight after giving birth to her second child. WeightWatchers, for example, is getting into the prescription weight-loss drug business. The $106 million acquisition of Sequence will give WW a foothold into the growing market for prescription drugs to manage weight loss. Ozempic has gained popularity in part due to celebrities using it for weight loss.

☆ Jenny Craig is reportedly winding down its weight-loss centers and warning of mass layoffs
▼ + stars: | 2023-04-28 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +2 min

New York CNN —Jenny Craig is reportedly shutting down some of its weight-loss centers and warning employees of mass layoffs amid upheaval in the industry from popular new prescription drugs like Ozempic. Jenny Craig alerted employees to potential layoffs as it begins “winding down physical operations” and hunts for a buyer, according to NBC News. Jenny Craig has nearly 500 weight-loss centers in the United States and Canada. We will have more details to share in the coming weeks as our plans are solidified,” a spokesperson for Jenny Craig said in a statement to CNN. Ozempic has gained popularity in part due to celebrities using it for weight loss.

☆ Here are Tuesday's biggest analyst calls of the day: Apple, Amazon, UPS, Netflix, WW, Disney & more
▼ + stars: | 2023-04-11 | by ( Michael Bloom | ) www.cnbc.com time to read: +9 min

Morgan Stanley names UnitedHealth a top pick Morgan Stanley says the healthcare company is best positioned in a recession. Morgan Stanley reiterates Netflix as equal weight Morgan Stanley said Netflix is the "streaming winner" but that it's "priced as such." Morgan Stanley downgrades Nasdaq to equal weight from overweight Morgan Stanley said that it has growth concerns for the exchange operator. JPMorgan upgrades Federated Hermes to overweight from underweight JPMorgan said the rate environment makes the capital market company's stock more attractive. Morgan Stanley upgrades AstraZeneca to overweight from equal weight Morgan Stanley said the pharmaceutical company is "leading the race" to outsmart cancer.

☆ WeightWatchers' parent rockets higher by 25% after Goldman says the stock will more than triple
▼ + stars: | 2023-04-11 | by ( Yun Li | ) www.cnbc.com time to read: +1 min

WW International , the parent WeightWatchers, could see its stock price more than triple as the diet company's new foray into obesity medications could result in a major turnaround, Goldman Sachs said. The Wall Street firm upgraded the stock to buy from neutral Monday evening and raised its 12-month price target to $13. The stock skyrocketed 28% in premarket trading Tuesday after closing Monday's trading at $4.12 apiece. Goldman turned bullish after WW acquired Sequence , a telehealth platform that provides its subscribers with access to GLP-1 medications such as Wegovy and Ozempic. "We believe a catalyst for a turnaround has emerged with its new obesity drug on-ramp solution," Goldman said.

☆ Goldman Sachs says WeightWatchers' latest deal could revive the company and help it bring in $1.4 billion by 2025
▼ + stars: | 2023-04-11 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

Goldman Sachs analysts said the deal could mean more than half a million new subscribers by 2025. According to Goldman Sachs analysts, the company's foray into weight-loss drugs through its acquisition of Sequence could mean a turnaround for the company. Goldman Sachs estimates that sales for obesity drugs like GLP-1s could reach $30 billion annually by 2032. Through Sequence alone, Goldman analysts said that WeightWatchers could add an extra half million subscribers, generating $455 million in new revenue by 2025. Goldman noted that WeightWatchers currently has 4 million subscribers and 20 million former subscribers in its roster.

☆ Stocks making the biggest moves premarket: Moderna, CarMax, Whirlpool and more
▼ + stars: | 2023-04-11 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

CarMax — Shares of the vehicle retailer soared 7% on the back of better-than-expected quarterly earnings. Upstart — Upstart fell about 2% after JPMorgan initiated coverage of the lending stock with an underweight rating, citing a worsening environment for loans. Whirlpool — Shares gained more than 2% after Goldman Sachs upgraded Whirlpool to buy from neutral. LendingClub — The lending platform gained 4.8% after JPMorgan initiated coverage of the stock as overweight. Array Technologies — Shares of the solar technology company gained 2% after Wolfe Research initiated coverage of Array with an outperform rating.

Mohawk Industries — Shares of the flooring manufacturer gained 5% after Loop Capital upgraded the company to buy from its previous hold rating. WisdomTree — Shares of the financial firm gained 3% after the company said it had $1.9 billion of net flows in March. New York Community Bancorp — Shares of the regional bank gained 2.7% after Jefferies upgraded the stock to buy from hold. LendingClub — The lending stock gained 5% after JPMorgan initiated coverage of the stock at overweight. Murphy Oil — The natural gas company's shares gained 2.6% after Truist upgraded shares to buy from hold.

☆ Final Trades: WW Grainger, Corteva, Wabtec & more
▼ + stars: | 2023-03-20 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: WW Grainger, Corteva, Wabtec & moreThe "Halftime Report" traders give their top picks to watch for the second half.

☆ WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
▼ + stars: | 2023-03-07 | by ( Andrea Petersen | ) www.wsj.com time to read: 1 min

WW, known for food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach. WW International Inc., known as WeightWatchers, is buying digital health company Sequence, marking the diet company’s move into the hot market for diabetes and obesity drugs including Ozempic and Wegovy. Sequence is a subscription service that offers telehealth visits with doctors who can prescribe the drugs. WeightWatchers, which has long promised to help customers lose weight through food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach.

☆ Stocks making the biggest premarket moves: Meta, Rivian, WW International, KeyCorp and more
▼ + stars: | 2023-03-07 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

WW International — Shares of company formerly known as Weight Watchers jumped as much as 17.6% in premarket trading after announcing a deal to acquire telehealth firm Sequence. The Wall Street firm said the aircraft's weight has raised questions and led him to wonder if the design is "overly aggressive." Its price target of $39 implies 24.5% upside from Monday's close. The Wall Street firm said there is a large unmet need for resistant hypertension treatment and said Mineralys has "potential best-in-class" data. The Wall Street firm said Hensai "outshines peers, with its superior scale and margin, and its strong project pipeline."

☆ WeightWatchers jumps into into the prescription weight loss drug business with Ozempic
▼ + stars: | 2023-03-07 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +2 min

New York CNN —WeightWatchers is getting into the booming prescription weight loss drug business. The GLP-1 agonists Sequence helps prescribe include Wegovy, Ozempic, and Rybelsus. The FDA approved Ozempic for the management of diabetes in 2017 and Wegovy for weight loss in 2021. Ozempic has gained popularity in part due to celebrities using it for weight loss. But there are many concerns with using diabetes drugs for weight loss, including high costs and shortages that are making it harder for people with diabetes to obtain the drugs.

☆ Top 10 things the Club is watching in the stock market Tuesday: Fed's Powell, Meta, obesity
▼ + stars: | 2023-03-07 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Meta Platforms ' (META) "year of efficiency" set to continue: Bloomberg is reporting job cuts in the thousands could happen as soon as this week. WW International (WW) is higher after announcing deal to acquire the anti-obesity-focused telehealth provider Sequence. (Jim Cramer's Charitable Trust is long META, LIN, CSCO, AMZN, LLY. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

☆ WeightWatchers stock surges 70% after company agrees to buy obesity treatment platform
▼ + stars: | 2023-03-07 | by ( Rebecca Picciotto | ) www.cnbc.com time to read: +1 min

Shares of WW International , also known as WeightWatchers, skyrocketed Tuesday after the company said it planned to buy Sequence, a telehealth platform that provides treatment for obesity. Shares of the company were down 57% over the past year as it struggled to pivot to wellness and move away from weight loss. Sistani took over as chief executive at the end of February, steering the company back toward weight loss messaging. The Sequence announcement comes as companies across the weight loss industry look to offer obesity medications as a pathway to customers looking to shed pounds. The trend has led to a shortage in medications like Ozempic, which are commonly prescribed for Type 2 diabetes.

☆ Under threat, Weight Watchers enters obesity drug space. Here's what it means for the stock
▼ + stars: | 2023-03-07 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +7 min

The company's sales have been in a steady multiyear decline after an attempt to de-emphasize weight loss and focus on wellness failed miserably. WW 1Y mountain The parent of Weight Watchers has seen its market value shrink as sales have dropped for several years. Another drug, Eli Lilly's Mounjaro, adds a second incretin hormone to the mix and has been shown to be even more successful with weight loss. This trend could provide an opportunity for the core Weight Watchers brand and its focus on behavior modification. That scenario assumes Weight Watchers continues to see membership erosion, while cost controls help minimize margin compression.

Search resuls for: "WW"

25 mentions found